NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders.

Area of Science:

• Immunology
• Genetics
• Internal Medicine

Background:

• Common Variable Immunodeficiency Disorders (CVID) are characterized by hypogammaglobulinaemia, leading to infections.
• CVID patients often develop additional complications such as granulomatous disease and enteropathy, with unclear causes.
• Identifying disease modifier genes is crucial for predicting and managing CVID complications.

Purpose of the Study:

• To investigate if NOD2 gene polymorphisms act as disease modifiers for enteropathic or granulomatous phenotypes in CVID.
• To analyze the association between specific NOD2 mutations and clinical manifestations in a large CVID cohort.

Main Methods:

• Genotyping of 285 CVID patients from UK and European centers using sequence-specific primers.
• Analysis of NOD2 polymorphisms (gly908arg, leu1007finsc, arg702trp) and their correlation with CVID phenotypes.
• Comparison of allele frequencies with UK immunocompetent controls.

Main Results:

• Arg702trp polymorphisms were less frequent in CVID patients with splenomegaly (P=0.038).
• Gly908arg polymorphisms were more prevalent in UK CVID patients with autoimmune disorders or enteropathy (P=0.049).
• NOD2 polymorphisms were not significantly associated with granulomatous phenotypes in CVID patients.

Conclusions:

• Specific NOD2 polymorphisms, particularly gly908arg, may be associated with enteropathy and autoimmune disorders in CVID patients.
• NOD2 polymorphisms do not appear to confer susceptibility to CVID itself.
• Further research into NOD2 as a modifier gene could improve clinical management of CVID complications.